Polynoma LLC
- Biotech or pharma, therapeutic R&D
Polynoma is developing its late-stage cancer vaccine, seviprotimut-L, for the adjuvant treatment of stage 2b and 2c melanoma in patients 60 years and younger, and has other cancer vaccine assets in discovery and pre-clinical stages of development.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}